Correlation Between Adaptimmune Therapeutics and Ibio
Can any of the company-specific risk be diversified away by investing in both Adaptimmune Therapeutics and Ibio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Adaptimmune Therapeutics and Ibio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Adaptimmune Therapeutics Plc and Ibio Inc, you can compare the effects of market volatilities on Adaptimmune Therapeutics and Ibio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Adaptimmune Therapeutics with a short position of Ibio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Adaptimmune Therapeutics and Ibio.
Diversification Opportunities for Adaptimmune Therapeutics and Ibio
-0.31 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Adaptimmune and Ibio is -0.31. Overlapping area represents the amount of risk that can be diversified away by holding Adaptimmune Therapeutics Plc and Ibio Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ibio Inc and Adaptimmune Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Adaptimmune Therapeutics Plc are associated (or correlated) with Ibio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ibio Inc has no effect on the direction of Adaptimmune Therapeutics i.e., Adaptimmune Therapeutics and Ibio go up and down completely randomly.
Pair Corralation between Adaptimmune Therapeutics and Ibio
Given the investment horizon of 90 days Adaptimmune Therapeutics Plc is expected to under-perform the Ibio. But the stock apears to be less risky and, when comparing its historical volatility, Adaptimmune Therapeutics Plc is 2.32 times less risky than Ibio. The stock trades about -0.1 of its potential returns per unit of risk. The Ibio Inc is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest 298.00 in Ibio Inc on November 27, 2024 and sell it today you would earn a total of 46.00 from holding Ibio Inc or generate 15.44% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Adaptimmune Therapeutics Plc vs. Ibio Inc
Performance |
| Timeline |
| Adaptimmune Therapeutics |
| Ibio Inc |
Adaptimmune Therapeutics and Ibio Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Adaptimmune Therapeutics and Ibio
The main advantage of trading using opposite Adaptimmune Therapeutics and Ibio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Adaptimmune Therapeutics position performs unexpectedly, Ibio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ibio will offset losses from the drop in Ibio's long position.The idea behind Adaptimmune Therapeutics Plc and Ibio Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Ibio vs. Jaguar Animal Health | Ibio vs. GeoVax Labs | Ibio vs. Ocugen Inc | Ibio vs. Tonix Pharmaceuticals Holding |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |